Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.18 – $1.63
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4M | $7.7M | $7.2M | $6.4M | $5.9M | $6.2M | $6.7M | $7.2M |
| Cost of revenue | $2.1M | $2.2M | $1.9M | $2.2M | $2.3M | $1.0M | $1.2M | $1.4M |
| Gross profit | $5.4M | $5.5M | $5.2M | $4.2M | $3.7M | $5.1M | $5.5M | $5.8M |
| Gross margin | 72.1% | 71.3% | 72.9% | 65.5% | 62.0% | 83.2% | 81.7% | 81.2% |
| R&D | $1.2M | $1.0M | $1.1M | $993.0K | $0 | $0 | $0 | $0 |
| Operating income | $160.7K | $373.9K | −$90.0K | −$1.1M | −$1.5M | $1.9M | $2.0M | $2.1M |
| EBITDA | $841.7K | $1.4M | $683.2K | $625.6K | −$1.0M | $2.7M | $11.5M | $2.2M |
| Net income | $161.6K | $386.8K | −$90.2K | −$249.9K | −$888.6K | $2.7M | $11.4M | $2.7M |
| Net margin | 2.2% | 5.0% | -1.3% | -3.9% | -15.0% | 43.0% | 171.0% | 37.3% |
| EPS (diluted) | 0.07 | 0.16 | -0.04 | -0.10 | -0.32 | 0.63 | 0.33 | 0.06 |
Annual figures · source: Financial Modeling Prep
DATATRAK INTL INC
No one on the platform currently holds DTRK.
No tracked institution reports a position in DTRK as of their last filing.
| Execution date | Ratio |
|---|---|
| 2013-06-04 | 1-for-12reverse |
No one on the platform has traded DTRK yet.
| $165839 |
| — |
| CTTHCTT Pharmaceutical Holdings, Inc. | $0.07 | +0.00% | $2M | — |
| CTVEFCertive Solutions Inc. | $0.00 | +0.00% | $418125 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at NaN× earnings vs its 0.8× historical median P/E.
Fair value ≈ $-0.09 · price $0.18 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.